future invasive procedures in the case of pleural exudative, such as pleuroscopy, should be based on more evidence.
Thus, the objective of the present study was to develop a predictive model that applied simple clinical and analytical parameters, with the goal of discriminating between MPE and non-MPE.
| MATERIAL S AND ME THODS
We analyzed the case records of patients who had a diagnosis of MPE or non-MPE (eg, tuberculous and parapneumonic) in Wenzhou Central Hospital, China, from January 2012 to June 2018. Ethics committee approval was obtained prior to the commencement of the study. Patients in whom pleural effusion was secondary to heart failure, pericardial disease, trauma, or pulmonary embolism were excluded from the analysis. Data collected at the time of admission and before any medical treatment occurred were considered for analysis. Basic demographic, clinical and bio-marker data were collected within 24 hours of hospitalization. Patients were divided into two groups: MPE and non-MPE.
MPE was defined by the presence of malignant cells from pleural effusion cytology or histopathology. Tuberculous was defined as caseating granulomatous inflammation present in a biopsy or a positive acid-fast bacilli stain or mycobacterial culture of pleural effusion. Parapneumonic was defined as abscess, bacterial pneumonia, or bronchiectasis. The lactate dehydrogenase (LDH, U/L) and adenosine deaminase (ADA, U/L) were analyzed using an Olympus AU5400 analyzer (Olympus, Tokyo, Japan). CEA was determined using electrochemiluminescence analyzer (MODULAR ANALYTICS Cobas E-170,Roche Diagnostics; Mannheim, Germany). And CX 21 Olympus binocular microscope was used for cell classification.
We used SPSS 23.0 and R software programs for statistical analysis. 7 results showed skewed distributions. Thus, these variables were log e -transformed for multivariate analysis. We constructed two predictive models to assess the probability of MPE: (a) clinical-radiological data only and (b) a combination of clinical-radiological data, the cancer ratio and CEA. Then, the performances of both predictive models were assessed using receiver operating characteristic (ROC) curves and measurements of calibration and classification accuracy. 8 The Hosme-Lemeshow goodness-of-fit test was examined to assess calibration. A P value <0.05 was considered statistically significant.
| RE SULTS
In total, data from 120 patients with MPE and 120 patients with non-MPE (93 tuberculous and 27 parapneumonic) were obtained retrospectively. The origins of the MPEs are shown in Table 1 . Table 2 shows the clinical-radiological and analytical characteristics of the patients. There were no significant differences between the two groups regarding whether the patients were smokers or not. MPE patients were significantly older (P < 0.01), had a higher prevalence of dyspnoea (P < 0.01), a higher prevalence of clinical symptoms for greater than 30 days (P < 0.01), a more serosanguinous appearance of pleural effusion (P < 0.01), more X-ray/CT images suggestive of malignancy (P < 0.01), less chest pain (P < 0.01), and a lower prevalence of fever and general syndrome (defined as asthenia, anorexia, and loss of weight) (P < 0.01) than non-MPE patients.
CEA, serum LDH, and the cancer ratio (serum LDH: pleural ADA ratio) were significantly higher in MPE patients than that in non-MPE patients (all P < 0.01). In contrast, polymorphonuclears, serum proteins, pleural proteins, serum LDH, and pleural effusion ADA were much lower (all P < 0.01).
Logistic regression analysis was performed to predict the diagnosis of MPE (Table 3) 10 Even though pleuroscopy can determine the cause of pleural effusion in patients with an accuracy of 95%, it is invasive and not available in most hospitals. 11, 12 Therefore, developing a highly accurate, less invasive, accessible and early detection method is imperative for diagnosing the cause of pleural effusions.
TA B L E 1 Origin of malignant pleural effusions

| D ISCUSS I ON
Binary logistic regression models were applied in the present study, and to quantify how good the predictions from the model performances were, the discrimination, calibration, diagnostic accuracy, selected variables were consistent with the usually described clinical characteristics for MPE and non-MPE. The variable with the greatest discriminatory capacity was the X-ray/CT images suggestive of malignancy, as such that their presence increased by 18 times the probability of the pleural effusion being malignant (Table 3) . It is consistent with Valdes L et al, 13 Ferreiro et al, 14 and Ferrer J et al 15 F I G U R E 1 ROC (receiver operating characteristics) of the two models studied F I G U R E 2 Calibration of the two predictive models studied Compared with non-MPE patients, MPE patients had a more frequent serosanguinous appearance of pleural effusion. 16 Luis Valdes et al 15 proposed a predictive MPE model that was composed of chest pain, fever and the presence of radiological images suggestive of malignancy that classified 87.2% of patients with MPE. In contrast, our model did not consider fever. The fact the studies used different methodologies may also contribute to these differences. In addition, chest pain is a common symptom in tuberculous pleural effusion, yet in MPE, it is rare. Thus, the predictive model in our study was constructed with X-ray/CT images suggestive of malignancy, the absence of chest pain, prevalence of clinical symptoms for greater than 30 days, and serosanguinous appearance of pleural effusion.
Model 2 was composed of clinical-radiological data (same as model 1) with the additional analytical variables of lnCEA and ln(cancer ratio). CEA was chosen because it is the most extensively studied predictor of MPE and shows a high diagnostic capacity for MPE. 6, [17] [18] [19] [20] Compared to the pleural carcinoembryonic antigen (pCEA), the sensitivity and specificity of the "cancer ratio" was found to be higher in the present study. The AUC for the cancer ratio and pCEA were 0.958 and 0.927, respectively. Additionally, Akash Verma et al 21 The combination of the cancer ratio, clinical-radiology, and CEA further increased the diagnostic yield of the cancer ratio in identifying MPE. In addition, the two models proposed here can be derived from routinely performed biochemical tests and clinical variables, and can accurately identify MPE without any additional tests, costs or time.
Serum LDH is a ubiquitous cellular enzyme that increases in response to tissue injury in a nonspecific manner. 22 This mechanism in malignancies is well studied and the diagnostic yield for MPE has been widely researched. 21, 23, 24 However, pleural ADA is deemed to be low in MPE. Consequently, we combined serum LDH and pleural ADA in the present study. 
TA B L E 4 Classification of the two prediction models
One limitation of the present study is that both predictive models were constructed based on patients that were retrospectively reviewed at a single center. The findings require validation in prospective and multicentre studies.
| CON CLUS ION
In summary, both models achieved a high diagnostic accuracy for the prediction of MPE. However, model 2, which comprises the cancer ratio, CEA, and clinical-radiological parameters, was superior to model 1.
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